Increased Gametocytemia after Treatment: An Early Parasitological Indicator of Emerging Sulfadoxine‐Pyrimethamine Resistance in Falciparum Malaria
Author(s) -
Karen I. Barnes,
Francesca Little,
Aaron Mabuza,
Nicros Mngomezulu,
J. Govere,
David N. Dürrheim,
Cally Roper,
Bill Watkins,
Nicholas J. White
Publication year - 2008
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/587645
Subject(s) - gametocyte , malaria , sulfadoxine/pyrimethamine , sulfadoxine , pyrimethamine , plasmodium falciparum , dhps , biology , drug resistance , virology , carriage , medicine , microbiology and biotechnology , immunology , pathology
Although malaria treatment aims primarily to eliminate the asexual blood stages that cause illness, reducing the carriage of gametocytes is critical for limiting malaria transmission and the spread of resistance.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom